Axelpharm is suing Wyeth Holdings over a compulsory license for an anticancer drug
The Russian Axelpharm is demanding a compulsory license from the American Pfizer, probably for an antitumor drug based on bosutinib,...
The Russian Axelpharm is demanding a compulsory license from the American Pfizer, probably for an antitumor drug based on bosutinib,...
The mortality rate of the Russian population from malignant neoplasms decreased by almost 6% compared to 2018, said the head...
American Pfizer is trying to recover more than 12.5 billion rubles from the bankrupt Nativa. Most likely, the pharmaceutical manufacturer...